Kershaw Patel is a Cardiology physician affiliated with Houston Methodist. OpenAlex indexes 195 publications with 3,501 citations (h-index 33).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6550 Fannin St Ste 1901
Houston, TX 770302719
Telephone
713-441-1100Provider last certified this registry record 8 Apr 2026.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Roche Diagnostics CorporationProgram year20251 payment
- Novo Nordisk IncProgram year20254 payments
- Amgen Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.6%Statin28.3%Rosuvastatin Calcium51%Atorvastatin Calcium46%Pravastatin Sodium2%Part D<11 patientsCalcium channel blocker10.9%Amlodipine Besylate91%Nifedipine Er9%Part D<11 patients+ 10 more classes in this area
Blood & clotting
9.7%Factor Xa inhibitor7.6%Eliquis51%Xarelto49%Part D≥21 patientsVitamin K antagonist1.3%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.6%SGLT2 inhibitor4.9%Farxiga66%Jardiance34%Part D≥16 patientsGLP-1 receptor agonist1.8%Ozempic100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiovascular Health in the Transition From Adolescence to Emerging Adulthood: A Scientific Statement From the American Heart Association
Journal of the American Heart Association
2025 - Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial
Journal of Cachexia Sarcopenia and Muscle
2024
Similar KOLs
Other experts from the same institution or the same specialty.
William Zoghbi, MD
Houston Methodist
Eleftherios Mylonakis, MD
Houston Methodist
Dipan Shah, MD
Houston Methodist
Adi Lador, MD
Houston Methodist
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”